Cargando…
OTHR-02. Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors
Brain metastatic patients have multiple metastatic lesions or diagnostically challenging asymptomatic lesions, making surgery an inadequate therapeutic option. Given the challenges related to systemic delivery of a majority of therapeutic agents across the BBB, engineered cell based therapies offer...
Autores principales: | Shah, Khalid, Kitamura, Yohei, Du, Wanlu, Kanaya, Nobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351185/ http://dx.doi.org/10.1093/noajnl/vdab071.057 |
Ejemplares similares
-
OTHR-13. IMPACT the brain: improving metastatic breast cancer patient access to coordinated treatment
por: Grogan, Nicole, et al.
Publicado: (2021) -
OTHR-05. Diagnosis and Treatment of Solitary Pituitary Metastatic Cancer: A Case Series
por: Shan, Changguo, et al.
Publicado: (2021) -
OTHR-03. Brain Metastasis Among Ovarian Cancer Patients
por: Limon, Dror, et al.
Publicado: (2021) -
OTHR-01. Unmet clinical needs in patients with brain metastases in the current treatment era
por: Eggen, Annemarie C, et al.
Publicado: (2021) -
OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
por: Kennedy, Lucy Boyce, et al.
Publicado: (2021)